4D Molecular Therapeutics Insider Trades

FDMT

Track insider trading activity from 4D Molecular Therapeutics executives and directors. See which insiders are buying and selling FDMT stock.

Trades Last 12 Months

FDMT Price

All Insider Trades for 4D Molecular Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Holding Value $580k 50,000 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$471k 50,000 shares
$9.42
$11.60
Milligan John F Director
Holding Value $870k 75,000 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$707k 75,000 shares
$9.42
$11.60
Tomasello Shawn Director
Holding Value $580k 50,000 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$471k 50,000 shares
$9.42
$11.60
Chacko Jacob Director
Holding Value $580k 50,000 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$471k 50,000 shares
$9.42
$11.60
Gray Susannah Director
Holding Value $580k 50,000 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$471k 50,000 shares
$9.42
$11.60
Theuer Charles Director
Holding Value $580k 50,000 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$471k 50,000 shares
$9.42
$11.60
Sblendorio Glenn Director
Holding Value $580k 50,000 shares
Last Trade
Jun 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$471k 50,000 shares
$9.42
$11.60
Kirn David See Remarks
Holding Value $12.3M 1,057,231 shares
Last Trade
Jun 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$19.3k 1,922 shares
$10.02
$11.60
Holding Value $2.54M 219,000 shares
Last Trade
Mar 25, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.16M 219,000 shares
$9.88
$11.60
Bizily Scott Chief Legal Officer
Holding Value $2.52M 217,000 shares
Last Trade
Mar 25, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.14M 217,000 shares
$9.88
$11.60
Gupta Ashoo Vp, Finance And Controller
Holding Value $141k 12,119 shares
Last Trade
Mar 20, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$9.35k 1,086 shares
$8.61
$11.60
Sblendorio Glenn Director
Holding Value $522k 45,000 shares
Last Trade
Jan 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$329k 45,000 shares
$7.30
$11.60
Theuer Charles Director
Holding Value $484k 41,684 shares
Last Trade
Dec 12, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$101k 9,333 shares
$10.84
$11.60
Milligan John F Director
Holding Value $392k 33,750 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$140k 33,750 shares
$4.15
$11.60
Gray Susannah Director
Holding Value $261k 22,500 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$93.4k 22,500 shares
$4.15
$11.60
Mehra Uneek See Remarks
Holding Value $1.51M 130,000 shares
Last Trade
Mar 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$538k 130,000 shares
$4.14
$11.60
Kamal Fariborz President & COO
Holding Value $2.07M 178,400 shares
Last Trade
Mar 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$739k 178,400 shares
$4.14
$11.60
Kim Robert Young Chief Medical Officer
Holding Value $1.07M 92,300 shares
Last Trade
Mar 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$382k 92,300 shares
$4.14
$11.60
Holding Value $52.9M 4,563,211 shares
Last Trade
Dec 09, 2024 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$3.84M 535,000 shares
$7.18
$11.60
Holding Value $49.3M 4,247,914 shares
Last Trade
Jan 04, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$10.5M 540,000 shares
$19.53
$11.60

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up